 BOSTON, Nov. 02, 2022 GLOBE NEWSWIRE -- Sensei Biotherapeutics, Inc. NASDAQ: SNSE, an immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer, today announced that John Celebi, President and Chief Executive Officer, will present at the 13th Annual Jefferies Global Healthcare Conference, being held in London, United Kingdom, on Thursday, November 17, 2022, at 7:25 a.m. GMT. 